Showing results (1491-1500 of 1,552) with videos related to
Sort By:
Pageof 156
Cell|July 5, 2011
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repairSalvatore Cortellino, Jinfei Xu, Mara Sannai, et al.Science (New York, N.Y.)|March 16, 2013
Real-time observation of surface bond breaking with an x-ray laserM Dell'Angela, T Anniyev, M Beye, et al.The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.Nature Reviews. Clinical Oncology|October 5, 2017
Radiomics: the bridge between medical imaging and personalized medicinePhilippe Lambin, Ralph T H Leijenaar, Timo M Deist, et al.Physical Review Letters|July 16, 2021
Ultrafast Adsorbate Excitation Probed with Subpicosecond-Resolution X-Ray Absorption SpectroscopyElias Diesen, Hsin-Yi Wang, Simon Schreck, et al.Haematologica|September 7, 2019
Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assayFanny Drieux, Philippe Ruminy, Ahmad Abdel-Sater, et al.Oncogene|December 16, 2020
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathwayAlexander Swoboda, Robert Soukup, Oliver Eckel, et al.Bulletin Du Cancer|November 12, 2003
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation]Sylvie Rostaing-Rigattieri, Hubert Rousselot, Ivan Krakowski, et al.The EMBO Journal|August 5, 2015
E-cadherin can limit the transforming properties of activating β-catenin mutationsDavid J Huels, Rachel A Ridgway, Sorina Radulescu, et al.Pageof 156